We found that the predictive value of IL-6 and YKL-40 in recurrent stroke, composite vascular event and poor functional outcome among the patients with acute ischemic stroke or TIA was more apparent than that of hsCRP and Lp-PLA2 mass and activity. The gene discussed is IL6; the disease is Stroke.